Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ADIR discloses alkaloid derivatives with improved potency and solubility

Aug. 6, 1999

Liposome initiates clinical trial of Evacet in combination with Herceptin

Aug. 6, 1999

Combination immunotherapy kills melanoma in mice

Aug. 6, 1999

Promising troponin I analogue identified

Aug. 5, 1999

Radicicol derivative depletes Hsp90-associated molecules, exhibits antitumor activity

Aug. 5, 1999

U.K. academics isolate novel cytotoxic agent from cyanobacterium

Aug. 4, 1999

Paxene launched in the Czech Republic

Aug. 4, 1999

Kirin Brewery patents quinoline derivatives with broad potential therapeutic application

Aug. 3, 1999

Licensing opportunity from NIH: method of inhibiting Hsp90 with novobiocin

Aug. 3, 1999

Ontogen completes phase I bioavailability study of MDR-modulating compound

Aug. 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...